Lumpy...
If you say you are long, I will accept that at face value. No hard feelings I hope from the previous posting. And please don't get me wrong...I don't criticize anyone for being critical of mngt....I was vigorously assailed (much more than what you endured from me) on the YMB as being a short....all for the infraction of being critical of DNDN management..(well, very critical..but civil), my 'problem' was simply that I couldn't understand how one would honestly doubt that manipulation of DNDN sh/pr has taken place, or how, in view of the published statistics re. Provenge efficasy, one could feel the constant short assault is somehow deserved. However upon further reflection of your posts, I see that your meaning may have been misunderstood by me, though I don't agree that both sides present compelling arguments. I find the arguments against Provenge receiving outright approval to be a bit shallow. Survival is the Gold standard after all. When one considers the superior efficacy/toxicity profile of Provenge vs. Taxotere...it seems Provenge rates as about as close to a slam-dunk as you will find in bio-tech.
Best wishes and success to you mate...amd again my apologies to you for implying you were anything but genuine in your posting.
